Highlights DIAGNOS Inc.

Equities

ADK

CA2524423068

Delayed Toronto S.E. Other stock markets 01:57:10 2024-04-29 pm EDT			5-day change	1st Jan Change
0.285 ^CAD	+1.79%		-3.39%	-29.63%

Apr. 16	DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification	CI
Apr. 02	DIAGNOS Inc. Appoints Philippe Couillard to Its Board of Directors	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification	Apr. 16	CI
Diagnos Raises C$182,000 in the Final Tranche of a Private Placement of Share Units	Mar. 22	MT
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 28	CI
Diagnos Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica	Dec. 11	MT
Diagnos Inc. Secures Exclusive Distribution Agreement for Canada with Essilorluxottica	Dec. 11	CI
DIAGNOS Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 28	CI
DIAGNOS Inc. Announces Commencement of its Innovative Deployment in an Advanced Screening Program At Canada's Presented Specialist Care Provider in Diabetes and Endocrinology	23-10-05	CI
DIAGNOS Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-24	CI
DIAGNOS Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-13	CI
DIAGNOS Inc. and IRIS, The Visual Group Strengthens Partnership with the Launch of "IRIS-ai Powered by DIAGNOS"	23-05-17	CI
Diagnos and ETS Unveil Method to Adapt Deep Learning Algorithms	23-02-28	MT
DIAGNOS and ETS to Present Research on Mass Screening for Macular Edema at ARVO 2023	23-02-14	CI
Diagnos Gets OK For the Use of Diabetic Retinopathy Screening Technology in Quebec Hospitals	23-01-31	MT
Diagnos Inc Gets the Green Light for the Use of Its Diabetic Retinopathy Screening Technology in Quebec Hospitals	23-01-31	CI
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-25	CI
DIAGNOS Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-29	CI
Diagnos Enters Retinal Diagnostics Market With New 3D Image Analysis Technology	22-10-27	MT
DIAGNOS Inc. Enters the Retinal Diagnostics Market with Its New 3D Image Analysis Technology	22-10-27	CI
DIAGNOS Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-25	CI
Diagnos Receives Costa Rica Govt Approval For its Artificial Intelligence Enabled Pathology Detection Systems	22-08-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DIAGNOS Inc.

Equities

ADK

CA2524423068

Highlights

Filters